Hematology

Latest updates in Advanced Systemic Mastocytosis from EHA 2022. Targeting systemic mastocytosis. Update in Haematology session EHA 2022, Prof. Olivier Hermine introduces the  session on overcoming the challenges in diagnosis and management of advanced systemic macrocytosis.

This series of webinars focusses on Beta-Thalassemia. These are scientific presentations and discussions for the purpose of scientific exchange.

This satellite symposium discusses current key topics in higher-risk MDS, including treatment outcome measures

The third of our six-part series focuses on new treatment options in paediatric thalassemia with expert Dr Immacolata Tartaglione, paediatrician at University of Campania Luigi Vanvitelli in Napoli, Italy.

The second of our six-part series focusing on increasing awareness of β-thalassaemia features Khaled Musallam, Clinical Professor at…

This presidential debate-style discussion explores the topic of biosimilars within haematology and oncology.

*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)

Cappellini shares her expert insights into β-thalassaemia with our chair, internationally renowned surgeon Jonathan Sackier. With a focus…